​
​

Moleculin Biotech (MBRX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Moleculin Biotech Revenue Highlights

00

Moleculin Biotech Revenue by Period

Moleculin Biotech Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Moleculin Biotech generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Moleculin Biotech Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$406.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--

Moleculin Biotech generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Moleculin Biotech Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ONTXTraws Pharma$226.00B$56.00K
CAPRCapricor Therapeutics$25.18M$2.26B
PULMPulmatrix$7.30M$366.00K
CBIOGyre Therapeutics$794.00K-
CYCCCyclacel Pharmaceuticals$420.00K$10.00
IKTInhibikase Therapeutics$260.50K-
VRAXVirax Biolabs Group$8.56K$76.50K
ANEBAnebulo Pharmaceuticals--
ANTXAN2 Therapeutics--
BPTHBio-Path--
MBRXMoleculin Biotech--
NXTCNextCure--
AKTXAkari Therapeutics--
PMVPPMV Pharmaceuticals--
ATXIAvenue Therapeutics--
CFRXContraFect--
ALLRAllarity Therapeutics--
DFFNCervoMed--

MBRX Revenue FAQ

What is Moleculin Biotech’s yearly revenue?

Moleculin Biotech's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. MBRX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Moleculin Biotech’s quarterly revenue?

Moleculin Biotech's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). MBRX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Moleculin Biotech’s revenue growth rate?

Moleculin Biotech's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.